Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers.
The development of new vasoactive drugs has increased the possibilities to treat patients with digital vasospasm, known as Raynaud's phenomenon. The purpose of this paper is to give a review of recent clinical trials and also a short review of the pathophysiological reasons for each type of pharmacological treatment.